Canada markets open in 5 hours 29 minutes

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.0500-0.0500 (-2.38%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 143.35M
Enterprise Value 131.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)27.11
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -5.93

Trading Information

Stock Price History

Beta (5Y Monthly) 1.46
52-Week Change 325.77%
S&P500 52-Week Change 323.57%
52 Week High 33.9800
52 Week Low 31.5500
50-Day Moving Average 32.5304
200-Day Moving Average 32.2178

Share Statistics

Avg Vol (3 month) 3105.36k
Avg Vol (10 day) 390.45k
Shares Outstanding 569.93M
Implied Shares Outstanding 669.93M
Float 856.54M
% Held by Insiders 122.93%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 4269.81k
Short Ratio (Apr 15, 2024) 40.12
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.02%
Shares Short (prior month Mar 15, 2024) 493.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.88%
Return on Equity (ttm)-390.89%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.72M
Net Income Avi to Common (ttm)-22.38M
Diluted EPS (ttm)-0.3800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.66M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)197.19k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.83
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-11.3M
Levered Free Cash Flow (ttm)-303.87k